Header Logo

Connection

MICHAEL BRAUN to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications MICHAEL BRAUN has written about Drug Resistance, Neoplasm.
MICHAEL BRAUN
Connection Strength
0.124
Drug Resistance, Neoplasm
  1. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer Med. 2021 12; 10(23):8581-8594.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.